Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epileptic Seizure”

1,465 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,465 results

Testing effectiveness (Phase 2)Study completedNCT03406702
What this trial is testing

CX-8998 for Absence Seizures

Who this might be right for
Epilepsy
Jazz Pharmaceuticals 7
Large-scale testing (Phase 3)WithdrawnNCT02174094
What this trial is testing

Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome

Who this might be right for
Dravet Syndrome
H. Lundbeck A/S
Not applicableStudy completedNCT00318929
What this trial is testing

Tolerability and Efficacy of Depakote-extended Release in the Elderly

Who this might be right for
ElderlyEpilepsySeizures
Virginia Commonwealth University 14
Large-scale testing (Phase 3)Study completedNCT03936777
What this trial is testing

Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

Who this might be right for
Dravet SyndromeLennox Gastaut SyndromeEpileptic Encephalopathy
Zogenix, Inc. 412
Large-scale testing (Phase 3)Study completedNCT00988429
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Who this might be right for
Partial Epilepsy
Bial - Portela C S.A. 653
Not applicableLooking for participantsNCT07013331
What this trial is testing

A PET-MRI Study of Serotoninergic Brainstem Pathway in Patients With Dravet Syndrome

Who this might be right for
EpilepsyDravet SyndromeDrug Resistant Epilepsy+1 more
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Not applicableStudy completedNCT00884351
What this trial is testing

Magnetoencephalography in Absence Seizures

Who this might be right for
Seizures
National Institute of Neurological Disorders and Stroke (NINDS) 5
Not applicableStudy completedNCT02415686
What this trial is testing

Cardiac Arrhythmias in Dravet Syndrome

Who this might be right for
Epilepsy
Stichting Epilepsie Instellingen Nederland 59
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Not applicableStudy completedNCT06812000
What this trial is testing

Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy

Who this might be right for
Post-stroke SeizurePost-stroke EpilepsyThrombolytic (t-PA) Treatment
Mazandaran University of Medical Sciences 199
Not applicableNot Yet RecruitingNCT07535736
What this trial is testing

Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury

Who this might be right for
Antiepileptic Efficacy and SafetyBrain Injuries
Assiut University 70
Large-scale testing (Phase 3)WithdrawnNCT05128344
What this trial is testing

Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Who this might be right for
Spasms, Infantile
Amzell
Testing effectiveness (Phase 2)Study completedNCT00416195
What this trial is testing

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

Who this might be right for
Epilepsy
Eisai Co., Ltd. 48
Not applicableUnknownNCT03741192
What this trial is testing

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs

Who this might be right for
Epilepsy Intractable
Brain Sentinel 58
Not applicableNot Yet RecruitingNCT07463222
What this trial is testing

Neuroendocrine Response in Pediatric Febrile Seizures

Who this might be right for
Febrile ConvulsionNeuroendocrine Stress ResponseFever
Aydin Adnan Menderes University 120
Not applicableStudy completedNCT03860467
What this trial is testing

Epileptic Seizures in Intensive Care Units

Who this might be right for
Epileptic Seizure
University Hospital, Basel, Switzerland 200
Post-approval studies (Phase 4)WithdrawnNCT02220972
What this trial is testing

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
Eisai Inc.
Not applicableStudy completedNCT02262156
What this trial is testing

CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients

Who this might be right for
DepressionEpilepsy, Temporal Lobe
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 15
Not applicableStudy completedNCT03857451
What this trial is testing

Treatment of Gait Disorders in Children With Dravet Syndrome

Who this might be right for
Dravet SyndromeSevere Myoclonic Epilepsy of Infancy
Universiteit Antwerpen 50
Next Page